Atlas Trials

Combination of Metformin With Gefitinib to Treat NSCLC

Clinical trial NCT01864681 · COMPLETED

Trial details

NCT number
NCT01864681
Sponsor
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
NSCLCEGFR Gene AmplificationAdvanced CancerStage IIIB NSCLCStage IV NSCLC
Start date
2013-05-01
Primary completion
2017-12-01
Enrollment
224

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.